Could a diabetes drug fix kidney disease by fixing fat?
NCT ID NCT07309094
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study looks at whether a type of diabetes medication (GLP-1 receptor agonists) can help people with chronic kidney disease by improving how their fat tissue works. Researchers will measure changes in fat around the kidneys and heart, as well as kidney function, in 250 adults with early-to-moderate kidney disease who also have obesity or type 2 diabetes. The goal is to see if treating fat tissue problems can slow kidney damage and reduce heart risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vithas Valencia Consuelo
RECRUITINGValencia, Valencia, 46007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.